Modular Medical director granted stock and options
Modular Medical, Inc. director Steven G. Felsher received equity compensation consisting of common shares and stock options.
Rhea-AI Filing Summary
Modular Medical, Inc. director Steven G. Felsher received equity compensation consisting of common shares and stock options. He was granted 25 shares of common stock at a stated price of $0.0000 per share under the company’s Outside Director Compensation Plan, bringing his direct common stock holdings to 8,498 shares.
He was also granted an option to purchase 250 shares of common stock at an exercise price of $4.88 per share, expiring on June 30, 2036. The option was fully vested and exercisable on the grant date. Share amounts reflect a 1-for-30 reverse stock split of the company’s common stock effected on March 31, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 275 shares
Grant/Award
2 txns
Insider
FELSHER STEVEN G
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Option to purchase common stock | 250 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 25 | $0.00 | $0.00 |
Holdings After Transaction:
Option to purchase common stock — 250 contracts (Direct);
Common Stock — 8,498 shares (Direct)
Footnotes (4)
- F1. These shares were issued to the Reporting Person pursuant to the Issuer's Outside Director Compensation Plan.
- F2. Share amount reflects the impact of a 1-for-30 reverse stock split of the Issuer's common stock effected on March 31, 2026.
- F3. The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.
- F4. In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."
Key Figures
Common shares granted: 25 shares
Common shares held after grant: 8,498 shares
Option grant size: 250 options
+3 more
6 metrics
Common shares granted
25 shares
Equity award to director on June 30, 2026
Common shares held after grant
8,498 shares
Total direct common stock ownership following transaction
Option grant size
250 options
New option to purchase common stock awarded to director
Option exercise price
$4.88 per share
Exercise price for 250-share option grant
Option expiration date
June 30, 2036
Expiration of granted stock option
Reverse stock split ratio
1-for-30
Reverse split of common stock effective March 31, 2026
Key Terms
Outside Director Compensation Plan, 1-for-30 reverse stock split, beneficial ownership, exercise price
4 terms
Outside Director Compensation Plan financial
"These shares were issued to the Reporting Person pursuant to the Issuer's Outside Director Compensation Plan."
1-for-30 reverse stock split financial
"Share amount reflects the impact of a 1-for-30 reverse stock split of the Issuer's common stock effected on March 31, 2026."
beneficial ownership financial
"column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1."
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
exercise price financial
"The option was granted ... and the option was fully vested and exercisable on the grant date."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did the Modular Medical (MODD) director acquire in this Form 4?
The director received a grant of 25 shares of common stock and an option for 250 shares. Both were awarded as equity compensation, not open-market purchases, under Modular Medical’s Outside Director Compensation Plan on June 30, 2026.
Was the Modular Medical (MODD) Form 4 transaction a stock purchase or a grant?
The filing reports a grant, not a market purchase. Steven G. Felsher received common shares and stock options as a compensation award, coded as an acquisition (transaction code A) rather than buying shares in the open market.
What is the exercise price and term of the new Modular Medical (MODD) stock options?
The granted option covers 250 shares of common stock with a $4.88 exercise price. It was fully vested and exercisable on the grant date and is scheduled to expire on June 30, 2036, giving a long exercise window.
Were the Modular Medical (MODD) options granted under a specific compensation plan?
Yes. The options were granted to the director under Modular Medical’s Outside Director Compensation Plan. The filing notes the option was fully vested and exercisable on the grant date, indicating it functions as immediate, long-dated equity compensation.
AI-generated analysis. How Rhea-AI works. Not financial advice.
